Difference between revisions of "Team:Bielefeld-CeBiTec/Project/translational system/translation mechanism"
Line 28: | Line 28: | ||
<h2> Adaption of the Translational Mechanism to Incorporate Non-canonical Amino Acids </h2> | <h2> Adaption of the Translational Mechanism to Incorporate Non-canonical Amino Acids </h2> | ||
<article> | <article> | ||
− | The genetic code, consisting of the four bases adenine, guanine, thymidine, and cytosine, provides the framework for the synthesis of peptides and proteins, and thus builds the foundation of all living organisms. Three bases of DNA in protein coding sequences determine an amino acid, and multiple amino acids in turn form a polypeptide. Every possible base triplet codes for an amino acid or a translation stop, such that there are no unoccupied triplets. In order to incorporate a non canonical amino acid into a polypeptide, it is necessary that a certain base triplet | + | The genetic code, consisting of the four bases adenine, guanine, thymidine, and cytosine, provides the framework for the synthesis of peptides and proteins, and thus builds the foundation of all living organisms. Three bases of DNA in protein coding sequences determine an amino acid, and multiple amino acids in turn form a polypeptide. Every possible base triplet codes for an amino acid or a translation stop, such that there are no unoccupied triplets. In order to incorporate a non canonical amino acid into a polypeptide, it is necessary that a certain base triplet is dedicated to encoding for this amino acid. As there are no unoccupied triplets available, an existing codon needs to be reassigned. The amber stop codon (UAG/TAG) has been a prominent candidate, as it is one of the three codons signaling translation stop and occurs relatively rarely (roughly 8% of all stop codons in <i>Escherichia coli</i> K-12 genome. An amber suppressor system, consisting of a mutated tRNA and its corresponding tRNA synthetase, is then used to replace the stop-function of the codon with the incorporation of the novel amino acid. More specifically, the tRNA is adapted to suppress the stop-function. In synthetic biology, this is often commonly achieved by exchanging a nucleotide at the anticodon part, such that the amber stop codon is read as a codon for an amino acid. Such systems are common in research (Liu <i>et. al.</i> 2010, Anaelle <i>et. al.</i> 2015, Santoro <i>et. al.</i> 2002). Especially the studies by Liu and Schultz (2010) served as a guideline for our own ncAA incorporation system, as they provide us with comprehensive information on the suppressor system. |
<br> | <br> | ||
<br> | <br> | ||
− | By the incorporation of the <a href=!https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/unnatural_base_pair/unnatural_base_pairs">unnatural base pairs (UBP)</a>, the translational system enables the recognition of the new bases and the interaction of a matching tRNA/synthetase pair. That is the starting point | + | By the incorporation of the <a href=!https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/unnatural_base_pair/unnatural_base_pairs">unnatural base pairs (UBP)</a>, the translational system enables the recognition of the new bases and the interaction of a matching tRNA/synthetase pair. That is the starting point for the engineering the of an orthogonal tRNA/synthetase pair for the translational incorporation of certain <a href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/toolbox">non-canonical amino acids (ncAA)</a>. |
− | In the process of | + | In the process of protein biosynthesis, the DNA is first transcribed into mRNA and in the next step into amino acid polypeptides. |
− | Therefore the ribosome binds on a certain position | + | Therefore, the ribosome binds on a certain position for the mRNA and supports the binding of the interaction for the mRNA and the matching amino acyl tRNA. |
− | The ribosome contains three binding sites. The tRNA first binds in the A site | + | The ribosome contains three binding sites. The tRNA first binds in the A site and the peptidyl tRNA is bound in the P-site. The polypeptide is then transferred from the peptidyl tRNA in the P-site to the aminoacyl-tRNA in the A-site. In the process of translocation, the ribosome moves on to the next codon on the mRNA and the tRNA is aminoacylated by the tRNA synthetase (aaRS). The tRNA leaves the complex of mRNA and ribosome through the E-site. |
Thus, the polypeptide chain is extended in numerous of these processes and the polypeptide is formed. | Thus, the polypeptide chain is extended in numerous of these processes and the polypeptide is formed. | ||
This complex mechanism had to be adapted due to the use of UBPs. | This complex mechanism had to be adapted due to the use of UBPs. |
Revision as of 18:34, 1 November 2017
Translational Mechanism
Short Summary
The incorporation of non-canonical amino acids (ncAAs) is only possible if the translational mechanism are adapted. One possible ways to incorporate the ncAAs are the repurposing of codons like the amber stop or rarely used leucine codons, another way would be the incorporation of an unnatural base into the DNA to get new codons. For both, an orthogonal tRNA/aminoacyl-synthetase is necessary, which could charge the ncAA to the tRNA.
Adaption of the Translational Mechanism to Incorporate Non-canonical Amino Acids
By the incorporation of the unnatural base pairs (UBP), the translational system enables the recognition of the new bases and the interaction of a matching tRNA/synthetase pair. That is the starting point for the engineering the of an orthogonal tRNA/synthetase pair for the translational incorporation of certain non-canonical amino acids (ncAA). In the process of protein biosynthesis, the DNA is first transcribed into mRNA and in the next step into amino acid polypeptides. Therefore, the ribosome binds on a certain position for the mRNA and supports the binding of the interaction for the mRNA and the matching amino acyl tRNA. The ribosome contains three binding sites. The tRNA first binds in the A site and the peptidyl tRNA is bound in the P-site. The polypeptide is then transferred from the peptidyl tRNA in the P-site to the aminoacyl-tRNA in the A-site. In the process of translocation, the ribosome moves on to the next codon on the mRNA and the tRNA is aminoacylated by the tRNA synthetase (aaRS). The tRNA leaves the complex of mRNA and ribosome through the E-site. Thus, the polypeptide chain is extended in numerous of these processes and the polypeptide is formed. This complex mechanism had to be adapted due to the use of UBPs.
tRNA/Aminoacyl-Synthetase
The first step of the two-step reaction is the formation of an aminoacylated intermediate by the reaction of the amino acid and ATP. This is possible through the Rossmann fold. This domain describes a six-stranded parallel β-sheet with connecting helices. The Rossmann fold acts homologous to the active site domains of hydrogenases and is responsible for binding ATP, the amino acid and the 3’-terminus of the tRNA.
The class I synthetases are monomeric synthetases and feature all structurally similar active site Rossmann fold domains in the region of the N-terminal. Beside this region, there are no significant structural or sequence similarities among the class I enzymes.
There is an acceptor binding site inserted into the Rossmann-fold domain at a common location which binds the single stranded terminal end of the tRNA, while its C-terminal domain binds in the minor groove of the L-shaped tRNA and the anticodon arm. That is the point for the discrimination among the different tRNAs. The binding requires the formation of a hairpin structure of the single stranded 3’-terminus with the amino acid and the ATP in the active site (Chang et al., 2010, Krebs et al., 2014).
Figure 1: Crystal structure of a class I tRNA/aminoacyl synthetase.
The tRNA is shown in red and the protein in blue (Krebs et al., 2014).
An Orthogonal tRNA/Aminoacyl-Synthetase Pair
Since the tRNA recognition by the aaRS can be domain or species specific (Kwok et al., 1980) a heterologous aaRS/tRNA pair from a different organism is used. A possible source for an orthogonal tRNA/synthetase pair to be applied in bacterial cells can be eukaryotic. However, the adaption of these tRNA/aaRS pair which aminoacylates in Escherichia coli is very difficult (Liu et al., 1999). In contrast, evolved synthetases from archaea can be expressed efficiently in E. coli (Wang et al., 2001, Wang et al., 2000) and at the same time are more similar to eukaryotic organisms than to the prokaryotic (Kwok et al., 1980, Zhang et al., 2005). The reason are significant differences in the acceptor stem and anticodon binding recognition domain between prokaryotic and archaea tRNA/aaRS (Wang et al., 2000).
One possible orthogonal tRNA/aaRS pair is the tyrosine tRNA/aaRS pair of Methanococcus jannaschii, where the first base pair of the acceptor stem CG as a tRNATyridentity element differs from those of E. coli tRNATyr containing a GC (Wang et al., 2001). The orthogonal tRNA/aaRS pair is incorporated as a response of the amber stop codon, which does not incorporate any of the 20 canonical amino acids. We use the amber stop codon (UAG), because this codon is rare in E.coli and incorporation of random amino acids has been shown before.
References
Wang L, Xie J, Schultz PG. (2006). Expanding the Genetic Code. Annu. Rev. Biophys. Biomol. Struct. 2006;35:225–49.
Liu CC, Schultz PG. (2010). Adding New Chemistries to the Genetic Code. Annu. Rev. Biochem. 2010;79:413–44.
Kwok Y, Wong JT. (1980). Evolutionary relationship between Halobacterium cutirubrum and eukaryotes determined by use of aminoacyl-tRNA synthetases as phylogenetic probes. Canadian Journal of Biochemistry. 58(3): 213-218
Krebs J.(2014) Lewin's GENES XI
Nov Y. 2011. When Second Best Is Good Enough: Another Probabilistic Look at Saturation Mutagenesis, Applied and Environmental Microbiology 0099-2240/12/12.00
Anaëlle, Lerche , Spicer, Davis. (2015), Designing logical codon reassignment–expanding the chemistry in biology. Chemical Science 6.1 (2015): 50-69
Stephen W. Santoro, Wang, Herberich, King, Schultz. (2002) An efficient system for the evolution of aminoacyl-tRNA synthetase specificity." Nature biotechnology 20.10